These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23905680)

  • 1. Quinazolin-4-one derivatives as selective histone deacetylase-6 inhibitors for the treatment of Alzheimer's disease.
    Yu CW; Chang PT; Hsin LW; Chern JW
    J Med Chem; 2013 Sep; 56(17):6775-91. PubMed ID: 23905680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of indole-piperazine derivatives as selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting activities and neuroprotective activities.
    Liang T; Xie Z; Dang B; Wang J; Zhang T; Luan X; Lu T; Cao C; Chen X
    Bioorg Med Chem Lett; 2023 Feb; 81():129148. PubMed ID: 36690041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer.
    Yang Z; Wang T; Wang F; Niu T; Liu Z; Chen X; Long C; Tang M; Cao D; Wang X; Xiang W; Yi Y; Ma L; You J; Chen L
    J Med Chem; 2016 Feb; 59(4):1455-70. PubMed ID: 26443078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a novel series of benzylether-containing cinnamoyl derivatives as histone deacetylase inhibitors.
    Jiao J; Fang H; Wang X; Zhu H; Jiang L; Xu W
    J Enzyme Inhib Med Chem; 2010 Feb; 25(1):132-8. PubMed ID: 19558346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of pyridone-based histone deacetylase inhibitors: approaches for metabolic stability.
    Cho M; Choi E; Yang JS; Lee C; Seo JJ; Kim BS; Oh SJ; Kim HM; Lee K; Park SK; Kwon HJ; Han G
    ChemMedChem; 2013 Feb; 8(2):272-9. PubMed ID: 23292995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and therapeutic implications of selective histone deacetylase 6 inhibitors.
    Kalin JH; Bergman JA
    J Med Chem; 2013 Aug; 56(16):6297-313. PubMed ID: 23627282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-exploration of tetrahydro-β-carboline scaffold: Discovery of selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting and neuroprotective activities.
    Wen W; Hu J; Wang C; Yang R; Zhang Y; Huang B; Qiao T; Wang J; Chen X
    Bioorg Med Chem Lett; 2024 Apr; 102():129670. PubMed ID: 38387692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, and Pharmacological Evaluation of Novel N-Acylhydrazone Derivatives as Potent Histone Deacetylase 6/8 Dual Inhibitors.
    Rodrigues DA; Ferreira-Silva GÀ; Ferreira AC; Fernandes RA; Kwee JK; Sant'Anna CM; Ionta M; Fraga CA
    J Med Chem; 2016 Jan; 59(2):655-70. PubMed ID: 26705137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel HDAC6 isoform selective chiral small molecule histone deacetylase inhibitors.
    Smil DV; Manku S; Chantigny YA; Leit S; Wahhab A; Yan TP; Fournel M; Maroun C; Li Z; Lemieux AM; Nicolescu A; Rahil J; Lefebvre S; Panetta A; Besterman JM; Déziel R
    Bioorg Med Chem Lett; 2009 Feb; 19(3):688-92. PubMed ID: 19111466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazolin-2,4-dione-Based Hydroxamic Acids as Selective Histone Deacetylase-6 Inhibitors for Treatment of Non-Small Cell Lung Cancer.
    Yu CW; Hung PY; Yang HT; Ho YH; Lai HY; Cheng YS; Chern JW
    J Med Chem; 2019 Jan; 62(2):857-874. PubMed ID: 30525585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of N-hydroxycinnamides capped with a naturally occurring moiety as inhibitors of histone deacetylase.
    Huang WJ; Chen CC; Chao SW; Lee SS; Hsu FL; Lu YL; Hung MF; Chang CI
    ChemMedChem; 2010 Apr; 5(4):598-607. PubMed ID: 20209563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided identification of new histone deacetylase 6 selective inhibitor with anti-sepsis activity.
    Yoo J; Kim SJ; Son D; Seo H; Baek SY; Maeng CY; Lee C; Kim IS; Jung YH; Lee SM; Park HJ
    Eur J Med Chem; 2016 Jun; 116():126-135. PubMed ID: 27060764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of aliphatic-chain hydroxamates capped with osthole derivatives as histone deacetylase inhibitors.
    Huang WJ; Chen CC; Chao SW; Yu CC; Yang CY; Guh JH; Lin YC; Kuo CI; Yang P; Chang CI
    Eur J Med Chem; 2011 Sep; 46(9):4042-9. PubMed ID: 21712146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a selective HDAC6 inhibitor active in neuroblasts.
    Zwick V; Simões-Pires CA; Nurisso A; Petit C; Dos Santos Passos C; Randazzo GM; Martinet N; Bertrand P; Cuendet M
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4955-4959. PubMed ID: 27650925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, synthesis, and pharmacological evaluation of spiropiperidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors.
    Varasi M; Thaler F; Abate A; Bigogno C; Boggio R; Carenzi G; Cataudella T; Dal Zuffo R; Fulco MC; Rozio MG; Mai A; Dondio G; Minucci S; Mercurio C
    J Med Chem; 2011 Apr; 54(8):3051-64. PubMed ID: 21417419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-alkylamides as a new class of synthetic histone deacetylase inhibitors. 1. Design, synthesis, biological evaluation, and binding mode studies performed through three different docking procedures.
    Mai A; Massa S; Ragno R; Cerbara I; Jesacher F; Loidl P; Brosch G
    J Med Chem; 2003 Feb; 46(4):512-24. PubMed ID: 12570373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of tetrahydroisoquinoline-based hydroxamic acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.
    Zhang Y; Feng J; Jia Y; Wang X; Zhang L; Liu C; Fang H; Xu W
    J Med Chem; 2011 Apr; 54(8):2823-38. PubMed ID: 21476600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6 as a target for antileukemic drugs in acute myeloid leukemia.
    Hackanson B; Rimmele L; Benkißer M; Abdelkarim M; Fliegauf M; Jung M; Lübbert M
    Leuk Res; 2012 Aug; 36(8):1055-62. PubMed ID: 22464548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly potent and selective histone deacetylase 6 inhibitors designed based on a small-molecular substrate.
    Suzuki T; Kouketsu A; Itoh Y; Hisakawa S; Maeda S; Yoshida M; Nakagawa H; Miyata N
    J Med Chem; 2006 Aug; 49(16):4809-12. PubMed ID: 16884291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of anthraquinone-based HDAC6 inhibitors.
    Song Y; Lim J; Seo YH
    Eur J Med Chem; 2019 Feb; 164():263-272. PubMed ID: 30597327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.